Volume 9, Issue 1
Editorialp. 1
Diagnosing catastrophic antiphospholipid syndrome: the necessity for clinical awareness
Author(s): R Cervera & G Espinosa
Editorialp. 5
Putting patients first: the need for evidence-based and patient-centered standards of care in rheumatoid arthritis
Author(s): T Stamm, M Stoffer, M de Wit, K Redlich, A Woolf & J Smolen
Brief Reportp. 8
Postmenopausal women with rheumatoid arthritis and anti-CCP antibodies have higher mortality
Author(s): BULLETIN BOARD
Brief Reportp. 8
Dramatic reduction in joint inflammation promised by new compound
Author(s): BULLETIN BOARD
Brief Reportp. 9
Childhood pain, adult chronic pain and fibromyalgia linked
Author(s): BULLETIN BOARD
Case Reportp. 11
Ankylosing tarsitis associated with psoriatic arthritis
Author(s): MA Khan, MS Thyagarajan & AV Ramanan
Research Articlep. 13
The efficacy of continuous versus intermittent celecoxib treatment in osteoarthritis patients aged <60 and �60 years
Author(s): MN Essex, PB Brown & GH Sands
Research Articlep. 21
The importance of serological and histopathological diagnosis of the different forms of systemic lupus erythematosus with and without lupus nephritis
Author(s): M Wisłowska, J Gozdowska & T Korcz
Perspective Articlep. 31
Improving outcome assessment in pediatric vasculitis
Author(s): P Doležalová
Review Articlep. 41
The future of treatment for antiphospholipid syndrome
Author(s): R Willis, EN Harris & S Pierangeli
Review Articlep. 59
The future of treatment for psoriatic arthritis
Author(s): BJ Sheane & V Chandran
Review Articlep. 73
The role of testosterone and other hormonal factors in the development of rheumatoid arthritis
Author(s): C Turesson & M Pikwer
Review Articlep. 89
Recent advances in the treatment of systemic lupus erythematosus
Author(s): V Rodriguez-Garcia, SS Dias & D Isenberg
